Your browser doesn't support javascript.
loading
Therapeutic resistance in acute myeloid leukemia cells is mediated by a novel ATM/mTOR pathway regulating oxidative phosphorylation.
Park, Hae J; Gregory, Mark A; Zaberezhnyy, Vadym; Goodspeed, Andrew; Jordan, Craig T; Kieft, Jeffrey S; DeGregori, James.
Afiliação
  • Park HJ; Department of Biochemistry and Molecular Genetics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, United States.
  • Gregory MA; Medical Scientist Training Program, University of Colorado Anschutz Medical Campus, Aurora, United States.
  • Zaberezhnyy V; Department of Biochemistry and Molecular Genetics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, United States.
  • Goodspeed A; Department of Biochemistry and Molecular Genetics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, United States.
  • Jordan CT; Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, United States.
  • Kieft JS; University of Colorado Comprehensive Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, United States.
  • DeGregori J; Department of Medicine, Section of Hematology, University of Colorado Anschutz Medical Campus, Aurora, United States.
Elife ; 112022 10 19.
Article em En | MEDLINE | ID: mdl-36259537

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Resistencia a Medicamentos Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Elife Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Resistencia a Medicamentos Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Elife Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos